Dongxue W.

PMAOS is building an AI-native operating system for robots and resource-constrained devices. It gives hardware teams a lighter software stack for applications, device services, communications, multimedia and AI—without the cost and complexity of maintaining a large general-purpose operating system. For robot builders, PMAOS is designed to: • shorten hardware and product bring-up • simplify sensor, actuator and device integration • reduce memory and runtime overhead • improve response across device control and LLM interaction • provide a reusable platform across multiple products This lets teams spend more time building robot behavior and user experience, and less time rebuilding the underlying software stack. PMAOS currently has customer programs covering 8.5 million contracted and planned devices across four ODMs, starting with feature phones and extending into robotics and other intelligent-device categories.

PIEZOLABS revolutionary vascular devices self-generate an electric potential upon implantation, precisely managing blood interaction. Tailored to either prevent or promote clot formation based on patient needs, it potentially eliminates / reduce the need for dual antiplatelet therapy (DAPT) post-procedure, reducing bleeding and thrombotic risks. Experience the future potential of vascular health with our cutting-edge technology.

Improving patient outcomes, increasing utilizable organs, and extending transplant longevity.

PMAOS is building an AI-native operating system for robots and resource-constrained devices. It gives hardware teams a lighter software stack for applications, device services, communications, multimedia and AI—without the cost and complexity of maintaining a large general-purpose operating system. For robot builders, PMAOS is designed to: • shorten hardware and product bring-up • simplify sensor, actuator and device integration • reduce memory and runtime overhead • improve response across device control and LLM interaction • provide a reusable platform across multiple products This lets teams spend more time building robot behavior and user experience, and less time rebuilding the underlying software stack. PMAOS currently has customer programs covering 8.5 million contracted and planned devices across four ODMs, starting with feature phones and extending into robotics and other intelligent-device categories.

PIEZOLABS revolutionary vascular devices self-generate an electric potential upon implantation, precisely managing blood interaction. Tailored to either prevent or promote clot formation based on patient needs, it potentially eliminates / reduce the need for dual antiplatelet therapy (DAPT) post-procedure, reducing bleeding and thrombotic risks. Experience the future potential of vascular health with our cutting-edge technology.

Improving patient outcomes, increasing utilizable organs, and extending transplant longevity.

The Haas Impact Fund invests in exciting early-stage impact-oriented startups. Student Venture Partners lead sourcing, diligence, and portfolio stewardship of early-stage social enterprises. Each Spring, the Venture Partners pitch recommendations to HIFs proprietary network of impact experts for a $75,000 investment from HIF, with the potential for additional funding from a select group of co-investors. Venture Partners source promising early-stage impact startups in the following impact areas: Financial Wellness, Food & Agriculture, Health, Housing/Workforce Development, Renewable Energy, Sustainable Products, Sustainable Services & Supply Chain, Technology for Development, Urban Innovation, Transportation & Sustainability, and Wellbeing.